Introduction
The immune system is remarkably versatile defense system that has evolved to defend itself against this vast range of harmful agents. Deficiency of defence mechanism may involve specific immune functions -humoral immunity cell mediated immunity or both -or nonspecific mechanisms such as phagocytosis and complement, *Corresponding Author:
vijay1318@gmail.com which augment and act in conjunction with specific immune processes. As immune system plays central role of in the pathophysiology of many diseases suggesting a common target for therapeutic action (Dahanukar, 1999; Puri, 2003) . Hence, drugs acting on the immune system are likely to influence many systems in the body. Natural adjuvants, synthetic agents, antibody reagents are used as immunosuppressive and immunostimulative agents but there are major limitation to the general use of these agents such as increased risk of infection and generalized effect throughout the immune system. Immunosuppression is a major drawback in conventional therapy of cancer such as radiation and chemotherapy. Both these method have severe side effect such as nausea, vomiting, alopecia and mucosal ulceration etc. Therefore a need arises for the development of newer immunomodulatory agents from natural source with more powerful activity and lesser side effects which act as effective substitute for chemical therapeutics. Modulation of immune responses to alleviate the diseases has been of interest for many years and the concept of "Rasayana" in Ayurveda is based on related principles. Immunostimulation in a drug-induced immunosuppression model and immunosuppression in an experimental hyper-reactivity model by the same preparation can be said to be true immunomodulation (Patwardhan et al., 1990 triterpenoids, glycosides and phenolic compounds in Aegle marmelos which was screened for antibacterial activity. The anti fungal activity of essential oils isolated from the leaves of Bael has been evaluated using spore germination assay. The cytoprotective activity of the extract of Aegle marmelos (AME) was evaluated in the Chinese hamster V79 cells in Vitro. G. J. Zlabinger et al (1994) has characterized the mode of action of coumarin as immunomodulatory and also Chaing LC et al (2003) shown that flavonoids, monoterpenoids, triterpenoids, glycosides and phenolic compounds shows immunomodulatory activities. Therefore in the present study the effect of Aegle marmelos plant species on cell mediated and humoral immunity was evaluated. Animals were divided into seven groups of six animals each. Group I (control group) and group II (cyclophosphamide treated control) received the vehicle (1% SCMC, p.o.) for a period of 7 days. Groups III-VII were given the Aegle marmelos (50-800 mg/kg, p.o.) daily for 7 days. The animals of groups II-VII were injected with cyclophosphamide (50 mg/kg, p.o.) on the 4th, 5th and 6th day, 1 h after the administration of the respective treatment. The animals were immunised by injecting 0.1 ml of 20% of fresh sheep red blood cells suspension intraperitonially on day 0. Blood samples were collected in microcentrifuge tubes from individual animal by retro-orbital plexus on the 7th day and serum was separated. Antibody levels were determined by haemagglutination technique. Briefly, equal volumes of individual serum samples of each group were pooled. Two fold dilutions of pooled serum samples were made in 25 x l volumes of normal saline in microtitration plate and to that were added 25 x l of 1% suspension of sheep red blood cells in saline. After mixing, the plates were incubated at room temperature for 1 h and examined for haemagglutination under microscope. The reciprocal of the highest dilution of the test serum giving agglutination was taken as the antibody titre. The thickness of the right hind footpad was measured using digital Vernier caliper on the 7th day. The mice were then challenged by injecting 20 x l of 1% SRBCs in right hind footpad and after 24 h of this challenge the foot thickness was measured again. The pre-and postchallenge difference in the thickness of footpad was expressed in mm and taken as a measure of DTH. Effect of test extract on HA titre and DTH response using SRBCs as an antigen in mice-15 days pretreatment. Mice were divided into six groups, each group containing six mice. Group I represented the control group (1% SCMC, p.o.). Groups II-VI received the Aegle marmelos (50-800 mg/kg, p.o.). The pre-treatment time of 15 days was based on the method described by Sharma et al. (1996) . Schedule for drug administration was 7 days prior to immunization (days −6, −5, −4, −3, −2, −1, 0) and 7 days after immunization (days +1, +2, +3, +4, +5, +6, +7), Blood samples were collected in microcentrifuge tubes from individual animal by retroorbital plexus on the 15th day and serum was separated. Antibody levels were determined by haemagglutination technique. Briefly, equal volumes of individual serum samples of each group were pooled. Two fold dilutions of pooled serum samples were made in 25 x l volumes of normal saline in microtitration plate and to that were added 25 x l of 1% suspension of sheep red blood cells in saline. After mixing, the plates were incubated at room temperature for 1 h and examined for haemagglutination under microscope. The reciprocal of the highest dilution of the test serum giving agglutination was taken as the antibody titre. The thickness of the right hind footpad was measured using digital Vernier caliper on the 15th day. The mice were then challenged by injecting 20 x l of 1% SRBCs in right hind footpad and after 24 h of this challenge the foot thickness was measured again. The pre-and post-challenge difference in the thickness of footpad was expressed in mm and taken as a measure of DTH.
Materials and methods

Plant Material
Plaque Forming Colony Test
Four days after immunization with SRBC and different treatments in mice, the PFC assay was performed using spleen cells according to the method of Jerne and Nordin (1963) . Spleen cells collected from individual animals (0.1 mL; 1 x 106 cells/0.1 mL), 0.4 mL of 0.5% "low melting point" agarose (GIBCO, Grand Island, NY, USA) in HBSS, and 50 μL of a suspension of 5% SRBC were added to test tubes at 37ºC and poured onto microscope slides containing a bottom layer of 0.5% agarose in water. The slides were then incubated for 2 h at 37ºC and 5% CO2. Guinea pig serum diluted 1:4 in HBSS was added to the slides and after another 40 min (37ºC and 5% CO2) incubation the number of plaques was counted and values were expressed as PFC per 106 cells. For the preparation of guinea pig serum as the complement source, animals were anesthetized before cardiac puncture and blood samples were collected. Serum was obtained and previously absorbed with SRBC before being stored at -70 o C.
Statistical Analysis.
All the results were expressed as mean ± standard error mean (S.E.M.). Data were analyzed using one-way ANOVA followed by Dunnett"s t-test. p<0.05 was considered as statistically significant. The analysis was carried out using Graph pad software of version 4. (Arul V et al., 2005) . Thus, the immunostimulatory effect produced by dried extract of Aegle marmelos in cyclophosphamideinduced immunosuppression may be due to cell mediated and humoral antibody mediated activation of T and B cells. It can therefore be concluded that Aegle marmelos is a potential immunostimulant against cytotoxic drugs and can be used as a complimentary therapeutic agent. Identification of antibody producing cells is based on the ability of the secreted IgM antibody to fix complement and thereby lyses the indicator erythrocytes. Spleen cells or peripheral blood lymphocytes, previously incubated with antigen, are mixed with sheep red blood cells (SRBC). After addition of compliment and incubation, plaques (clear areas) caused by the lysis of SRBC appear in the otherwise cloudy layer. Antibody forming cells can be detected by the appearance of plaques. The number of plaques obtained is proportional to the number of antibody producing lymphocytes in the cell population. Aegle marmelos extract was found to increase the circulating antibody titre and antibody forming cells. In fact, antibody forming cells shown significant increased as compared to control group (P < 0.001) and shown dose dependent increase. Phytochemical investigations on Aegle marmelos revealed the presence of different types of compounds. It contain Scopoletine (7-Hydroxy-6-methoxy coumarin), Aegle marmelos extract contains a triterpinoid, lupeol (E. Lambertini et al, 2005) which is capable of inhibiting cell proliferation. It also contain inorganic trace elements such as Cu, Ni, Zn, K and Na where as Fe, Cr and V levels found in marginal levels (R. T. Narendhirakannan et al, 2005) .A new 7-geranyloxy coumarin[7-(2,6-dihydroxy-7-methoxy-7-methyl-3-octaenyloxy)coumarin] named marmenol (M. S. Ali et al, 2004) has been isolated from the fruit extract of Aegle marmelos. In addition to marmenol, several known compounds, praealtin D, trans-cinnamic acid, valencic acid, 4-methoxy benzoic acid, betulinic acid, cis and transcoumaroyltyramine, montanine and rutaretin have also been obtained from the extract. These observations indicate that various phytochemical like triterpinoid, coumarins have the capacity to modulate the immune response. There is a need for detailed investigation of the mechanism of modulation of immunoglobulin isotype and based on that, a possible therapeutic can be visualized. Control: 1% Sodium carboxy methyl cellulose; n=6 per group comparison of I with II, III, IV, V, n.s., Not significant, * p < 0.05., ** p < 0.01., *** p < 0.001. Control: 1% Sodium carboxy methyl cellulose; n=6 per group comparison of I with II, III, IV, V, n.s., Not significant, * p < 0.05., ** p < 0.01., *** p < 0.001. Control: 1% Sodium carboxy methyl cellulose; n=6 per group comparison of I with II, III, IV, V, n.s., Not significant, * p < 0.05., ** p < 0.01., *** p < 0.001.
Result
Conclusion
Fig 4:
Effect of test extracts SDEAM on HA Titre.
Control: 1% Sodium carboxy methyl cellulose; n=6 per group comparison of I with II, III, IV, n.s., Not significant, * p < 0.05., ** p < 0.01., *** p < 0.001. Control: 1% Sodium carboxy methyl cellulose; n=6 per group comparison of I with II, III, IV, n.s., Not significant, * p < 0.05., ** p < 0.01., *** p < 0.001.
Fig 6:
Effect of test extracts SDEAM on plaque forming cells.
Control: 1% Sodium carboxy methyl cellulose; n=6 per group comparison of I with II, III, IV, n.s., Not significant, * p < 0.05., ** p < 0.01., *** p < 0.001
Fig 7:
Effect of test extracts SDEAM on plaque forming cells. Results are expressed as a percentage change in no of plaques.
Control: 1% Sodium carboxy methyl cellulose; n=6 per group comparison of I with II, III, IV, n.s., Not significant, * p < 0.05., ** p < 0.01., *** p < 0.001. 
